SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $590,000 | +34.7% | 13,000 | 0.0% | 0.72% | +41.5% |
| Q2 2017 | $438,000 | +13.8% | 13,000 | 0.0% | 0.51% | +20.9% |
| Q1 2017 | $385,000 | +7.8% | 13,000 | 0.0% | 0.42% | +10.5% |
| Q4 2016 | $357,000 | -55.0% | 13,000 | 0.0% | 0.38% | -49.3% |
| Q3 2016 | $793,000 | +219.8% | 13,000 | 0.0% | 0.75% | +223.7% |
| Q2 2016 | $248,000 | -2.4% | 13,000 | 0.0% | 0.23% | 0.0% |
| Q1 2016 | $254,000 | -54.4% | 13,000 | -9.9% | 0.23% | -46.8% |
| Q4 2015 | $557,000 | +20.3% | 14,425 | 0.0% | 0.44% | +17.5% |
| Q3 2015 | $463,000 | +5.5% | 14,425 | 0.0% | 0.37% | +24.1% |
| Q2 2015 | $439,000 | +128.6% | 14,425 | 0.0% | 0.30% | +109.1% |
| Q1 2015 | $192,000 | -13.9% | 14,425 | -6.5% | 0.14% | +19.2% |
| Q4 2014 | $223,000 | +10.9% | 15,425 | +61.9% | 0.12% | +11.1% |
| Q3 2014 | $201,000 | -2.9% | 9,525 | +10.4% | 0.11% | -1.8% |
| Q1 2014 | $207,000 | -3.3% | 8,625 | -18.1% | 0.11% | -5.2% |
| Q4 2013 | $214,000 | -30.7% | 10,525 | +60.9% | 0.12% | -33.7% |
| Q3 2013 | $309,000 | +35.5% | 6,540 | +9.0% | 0.18% | +35.7% |
| Q2 2013 | $228,000 | – | 6,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |